Within the human body, a quiet truce has long existed between our immune systems and the viruses that never truly leave us — chickenpox, Epstein-Barr, cytomegalovirus, all held in careful suspension. New peer-reviewed research now suggests that severe COVID-19 can shatter that truce, rousing dormant infections in otherwise healthy people and setting in motion a cascade that may explain both the autoimmune complications and the lingering suffering known as long COVID. The finding reframes a central mystery of the pandemic: not why COVID-19 harms the vulnerable, but why it sometimes refuses to r
Severe COVID-19 Linked to Reactivation of Dormant Viruses, Study Finds
Severe COVID-19 patients experience complications from viral reactivation, including autoimmune disease and long COVID symptoms affecting quality of life.
Severe COVID jolts dormant viruses awake inside the body
Mark
So the study is saying that COVID-19 wakes up viruses that were already inside people's bodies?
Mimi
Exactly. Most of us carry these dormant viruses from childhood infections—chickenpox, Epstein-Barr. They're asleep, controlled by a healthy immune system. Severe COVID seems to disrupt that control.
Mark
And that's what causes long COVID symptoms?
Mimi
It appears to be part of it. The reactivated viruses trigger immune responses that can damage the body's own tissues, causing autoimmune problems and persistent symptoms.
Mark
But these were healthy people before they got COVID?
Mimi
Yes. That's what makes this significant. It's not about people with weak immune systems. It's about what severe COVID does to an otherwise normal immune response.
Mark
What happens next? Can doctors do anything about it?
Mimi
If they can identify which patients are at risk for reactivation, they might be able to intervene—either preventing it or managing it before it causes long-term damage. That's where the real clinical opportunity lies.
Le Pouls
- Severe COVID-19 doesn't just attack directly — it appears to destabilize the immune system enough to awaken latent viruses that healthy bodies had quietly contained for years or decades.
- These reactivated infections may then provoke the immune system into attacking the body's own tissues, triggering autoimmune disease in patients who had no prior vulnerability.
- The discovery reframes long COVID's most baffling symptoms — crushing fatigue, brain fog, persistent pain — as potentially driven by reawakened viruses rather than COVID-19's direct damage alone.
- Crucially, this mechanism targets previously healthy individuals, meaning severity of infection, not pre-existing weakness, is the determining factor.
- Researchers now see a path forward: identifying high-risk patients early and developing interventions that prevent reactivation or blunt its consequences before long-term damage sets in.
Within the human body, a quiet truce has long existed between our immune systems and the viruses that never truly leave us — chickenpox, Epstein-Barr, cytomegalovirus, all held in careful suspension. New peer-reviewed research now suggests that severe COVID-19 can shatter that truce, rousing dormant infections in otherwise healthy people and setting in motion a cascade that may explain both the autoimmune complications and the lingering suffering known as long COVID. The finding reframes a central mystery of the pandemic: not why COVID-19 harms the vulnerable, but why it sometimes refuses to release even the strong.
Most people carry viruses that have gone dormant inside them — chickenpox, Epstein-Barr, cytomegalovirus — held quietly in check by a functioning immune system. A new peer-reviewed study suggests that severe COVID-19 can disturb this long-standing equilibrium, jolting those sleeping infections awake and potentially explaining some of the pandemic's most troubling and persistent aftereffects.
When COVID-19 becomes severe enough to hospitalize a patient, the immune system's response appears to create conditions that allow these latent viruses to reactivate. The reactivated infections then trigger a secondary immune response — one that may turn against the body's own tissues, producing autoimmune disease. This same mechanism may underlie the constellation of long COVID symptoms: fatigue, cognitive difficulties, breathlessness, and pain that outlast the original illness by weeks or months.
What gives the finding particular weight is that it applies to people who were previously healthy. These are not individuals with obvious immune vulnerabilities — they are ordinary people whose immune systems were functioning normally until severe COVID-19 arrived. The virus's intensity, not any pre-existing condition, appears to be what determines whether dormant infections are given the opportunity to resurface.
The research opens new treatment possibilities. If clinicians can identify which patients face the highest risk of viral reactivation, earlier interventions may prevent the worst long-term consequences. For those already living with long COVID, the study offers a reorienting insight: some of their suffering may originate not from COVID-19's direct damage, but from the older, quieter viruses it disturbed along the way.
Most people carry a collection of viruses that have gone dormant inside their bodies—chickenpox, Epstein-Barr virus, cytomegalovirus—held in check by a functioning immune system. A new study published in a peer-reviewed journal suggests that severe COVID-19 can jolt these sleeping infections awake, potentially explaining why some patients develop autoimmune complications and why others struggle with persistent symptoms long after the acute illness has passed.
The research examined what happens at the cellular level when COVID-19 becomes severe enough to hospitalize a patient. In these cases, the immune system's response to the virus appears to create conditions that allow previously dormant infections to reactivate. This reactivation isn't merely an incidental finding—it may be a key mechanism driving some of the most troubling long-term health consequences that plague COVID survivors.
For people who have recovered from severe COVID-19, the implications are significant. The study suggests that viral reactivation could be responsible for the autoimmune diseases some patients develop in the months following infection. It may also help explain the constellation of symptoms that characterize long COVID: fatigue, cognitive difficulties, shortness of breath, and pain that persist for weeks or months after the initial infection has cleared.
The mechanism appears to work like this: when COVID-19 becomes severe, it overwhelms the immune system in ways that compromise the body's ability to keep latent viruses suppressed. Those dormant infections, sensing an opportunity, begin to replicate again. The immune system then mounts a response not just to the reactivated viruses but potentially to the body's own tissues, triggering autoimmune complications.
What makes this finding particularly important is that it applies to people who were previously healthy. These are not immunocompromised individuals with obvious vulnerability to infection. They are ordinary people whose immune systems were functioning normally until COVID-19 arrived. The virus's severity, not any pre-existing weakness, appears to be the determining factor in whether dormant viruses wake up.
Understanding this mechanism opens new avenues for treatment. If researchers can identify which patients are at highest risk for viral reactivation, they might be able to intervene earlier with therapies designed to prevent reactivation or manage its consequences. For patients already experiencing long COVID symptoms, the discovery suggests that some of their suffering may stem from these reactivated infections rather than from direct damage caused by COVID-19 itself.
The study represents a step toward explaining one of the pandemic's most persistent mysteries: why some people recover fully from COVID-19 while others are left with debilitating symptoms that resist conventional treatment. As researchers continue to investigate viral reactivation, they may uncover not just better ways to treat long COVID but also new insights into how severe infections affect the immune system more broadly.
Envie de l'histoire complète ?
Lire l'original sur Google News ↗
Health & Medicine